Speech-Evoked Auditory Potentials: Multisite Pediatric Evaluation
Starting soon · Not applicable
Conditions studied: Hearing Impairment
In brief
The goal of this study is to evaluate the sensitivity of a newly-developed prototype device in its ability to measure brain responses to speech sounds in an infant population. The main research questions are: 1) Is the prototype sensitive to brain response differences from infants with hearing loss with and without hearing aids? and 2) How do the measured brain responses from infants with hearing loss compare to infants with normal hearing who are the same age? Participants will have their brain responses measured using the prototype in response to average-level non-sense speech sounds across 1 to 2 sessions in a "no-hearing aids" condition. Participants with hearing loss who are already fit with hearing aids will additionally undergo a "with hearing aids" recording condition.
Key facts
- Study ID
- NCT07392164
- Run by
- Susan Scollie
- People needed
- 20
- Starts
- 2026-03-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2026-02-06
Who can join
Age: 0 and older, up to 2. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Infants (3 to 24 months of age) with normal hearing who have passed their audiological diagnostic evaluation
- Infants (3 to 24 months of age) identified with hearing loss at their audiological diagnostic evaluation, whose parents have chosen spoken language as their form of communication, and who have been prescribed and fitted with a hearing aid(s).
You may not qualify if…
- Participants who have abnormal middle ear measure results or occluding ear wax will be excluded.
Where it is running
- National Acoustic Laborartory — Macquarie Park, Sydney, Australia
- Dalhousie University — Halifax, Nova Scotia, Canada
- National Centre for Audiology at Western University — London, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.